This is a common situation right now. Here are your realistic options to consider: Compounded GLP-1s (Semaglutide) Possible, but with important caveats: Hims/Hers, LifeMD, Ro offer compounded semaglutide, typically $200-300/month Since brand-name Wegovy is no longer on the FDA shortage list, compounding pharmacies may soon lose legal authority to make it - this is an evolving situation Quality varies; look for pharmacies using 503B outsourcing facilities for better oversight Potentially Better Alternatives First Appeal your denial: Paperwork AI or your doctor can help draft appeals Many denials get overturned with prior authorization documentation Manufacturer savings programs: Novo Nordisk's savings card can reduce Wegovy to ~$650/month or less if you have commercial insurance Consider Zepbound (tirzepatide): Often easier to get approved than Wegovy May actually be more effective Eli Lilly's savings program can bring it to ~$550/month Retail alternatives: Ozempic (same drug, different indication) sometimes easier to approve My Honest Recommendation Talk to your doctor about switching the prescription to Zepbound before going the compounding route, given the regulatory uncertainty. Would you like more detail on any of these options?
Mentioned in position 4 of 6
Read full answer with sources →